COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 171 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,078,476 | +4.7% | 48,254 | +0.7% | 0.19% | +4.9% |
Q2 2023 | $1,029,822 | -13.7% | 47,921 | -3.7% | 0.18% | -21.1% |
Q1 2023 | $1,193,431 | -3.7% | 49,747 | -6.9% | 0.23% | -11.8% |
Q4 2022 | $1,239,089 | +35.6% | 53,409 | -6.4% | 0.26% | +20.6% |
Q3 2022 | $914,000 | -17.5% | 57,058 | -8.8% | 0.22% | -17.4% |
Q2 2022 | $1,108,000 | -16.0% | 62,531 | -3.5% | 0.26% | 0.0% |
Q1 2022 | $1,319,000 | +1.1% | 64,803 | -7.2% | 0.26% | +1.1% |
Q4 2021 | $1,305,000 | -3.9% | 69,837 | +1.5% | 0.26% | -37.9% |
Q3 2021 | $1,358,000 | +1.3% | 68,812 | +21.3% | 0.42% | +6.3% |
Q2 2021 | $1,341,000 | +1.5% | 56,722 | +1.8% | 0.40% | -18.0% |
Q1 2021 | $1,321,000 | +23.0% | 55,729 | +3.9% | 0.48% | +14.2% |
Q4 2020 | $1,074,000 | +31.3% | 53,624 | +36.5% | 0.42% | -1.6% |
Q3 2020 | $818,000 | +58.2% | 39,293 | +32.9% | 0.43% | +19.2% |
Q2 2020 | $517,000 | +6.8% | 29,568 | -0.2% | 0.36% | -24.8% |
Q1 2020 | $484,000 | -25.1% | 29,616 | -5.6% | 0.48% | -11.6% |
Q4 2019 | $646,000 | – | 31,383 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |